Clinical trials
Observational Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
340 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 9 |
| 2008 | 21 |
| 2009 | 15 |
| 2010 | 16 |
| 2011 | 14 |
| 2012 | 10 |
| 2013 | 7 |
| 2014 | 12 |
| 2015 | 12 |
| 2016 | 17 |
| 2017 | 9 |
| 2018 | 21 |
| 2019 | 30 |
| 2020 | 22 |
| 2021 | 20 |
| 2022 | 26 |
| 2023 | 16 |
| 2024 | 16 |
| 2025 | 19 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 185 |
| Recruiting | 54 |
| Unknown status | 40 |
| Terminated | 20 |
| Active, not recruiting | 18 |
| Withdrawn | 13 |
| Not yet recruiting | 7 |
| Suspended | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 36 |
| Bayer | 12 |
| Ipsen | 9 |
| Bristol-Myers Squibb | 8 |
| Radboud University Medical Center | 8 |
| GlaxoSmithKline | 6 |
| RenJi Hospital | 6 |
| Spanish Oncology Genito-Urinary Group | 6 |
| First Affiliated Hospital of Fujian Medical University | 5 |
| National Cancer Institute (NCI) | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 340 |
| Kidney Neoplasms | 74 |
| Melanoma | 24 |
| Neoplasms | 22 |
| Urinary Bladder Neoplasms | 22 |
| Carcinoma, Non-Small-Cell Lung | 21 |
| Carcinoma, Hepatocellular | 20 |
| Pancreatic Neoplasms | 18 |
| Breast Neoplasms | 16 |
| Lung Neoplasms | 16 |
Trials
Showing 76 to 100 of 340. Each trial links to its page on Pharma Observatory.
240 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.